logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9878002 B1

PDFFull Text
Date of Patent:
Jan. 30, 2018

Filed:

Jan. 24, 2014

Compositions and methods involving endogenous retrovirus proteins

Applicant:

Regents of the University of Minnesota, Minneapolis, MN (US);

Inventors:

Robyn Lynn Leary, La Jolla, CA (US);

Anindya Bagchi, Minneapolis, MN (US);

Aaron Lyman Sarver, St. Paul, MN (US);

Assignee:

REGENTS OF THE UNIVERSITY OF MINNESOTA, Minneapolis, MN (US);

Attorney:

Mueting, Raasch & Gebhardt, PA

Primary Examiner:

Janet L Andres

Assistant Examiner:

M Franco Salvoza

Int. Cl.
CPC ...
C12N 15/00 (2006.01); A61K 38/16 (2006.01); C07K 14/005 (2006.01); A61K 39/42 (2006.01); A61K 39/395 (2006.01); A61K 38/17 (2006.01); C12Q 1/68 (2006.01); C12Q 1/70 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/162 (2013.01); A61K 38/1758 (2013.01); A61K 39/39558 (2013.01); A61K 39/42 (2013.01); A61K 48/0058 (2013.01); C07K 14/005 (2013.01); C12Q 1/68 (2013.01); C12Q 1/702 (2013.01); A61K 48/00 (2013.01); A61K 2039/507 (2013.01); C12N 2740/10033 (2013.01); C12Q 2600/118 (2013.01);
Abstract

This disclosure describes methods and compositions that involve endogenous retrovirus proteins as diagnostic markers and/or therapeutic agents. The detection of endogenous retrovirus envelope proteins on a cell surface can indicate early neoplasticity of the cell. Antibody compositions that specifically bind to cell-surface-expressed endogenous retrovirus proteins may be used in such diagnostic methods. Overexpression of the endogenous retrovirus proteins can slow cell growth and decrease cell viability.

Find Patent Forward Citations

Quick Actions:

Leary, Robyn. (2018). Compositions and methods involving endogenous retrovirus proteins (U.S. Patent No. 9878002). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9878002

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…